Glucoregulatory Properties of a Protein Hydrolysate from Atlantic Salmon (Salmo salar): Preliminary Characterization and Evaluation of DPP-IV Inhibition and Direct Glucose Uptake In Vitro

Christian Bjerknes,Sileshi Gizachew Wubshet,Sissel Beate Rønning,Nils Kristian Afseth,Crawford Currie,Bomi Framroze,Erland Hermansen

DOI: https://doi.org/10.3390/md22040151

2024-03-29

Marine Drugs

Abstract:Metabolic disorders are increasingly prevalent conditions that manifest pathophysiologically along a continuum. Among reported metabolic risk factors, elevated fasting serum glucose (FSG) levels have shown the most substantial increase in risk exposure. Ultimately leading to insulin resistance (IR), this condition is associated with notable deteriorations in the prognostic outlook for major diseases, including neurodegenerative diseases, cancer risk, and mortality related to cardiovascular disease. Tackling metabolic dysfunction, with a focus on prevention, is a critically important aspect for human health. In this study, an investigation into the potential antidiabetic properties of a salmon protein hydrolysate (SPH) was conducted, focusing on its potential dipeptidyl peptidase-IV (DPP-IV) inhibition and direct glucose uptake in vitro. Characterization of the SPH utilized a bioassay-guided fractionation approach to identify potent glucoregulatory peptide fractions. Low-molecular-weight (MW) fractions prepared by membrane filtration (MWCO = 3 kDa) showed significant DPP-IV inhibition (IC50 = 1.01 ± 0.12 mg/mL) and glucose uptake in vitro (p ≤ 0.0001 at 1 mg/mL). Further fractionation of the lowest MW fractions (<3 kDa) derived from the permeate resulted in three peptide subfractions. The subfraction with the lowest molecular weight demonstrated the most significant glucose uptake activity (p ≤ 0.0001), maintaining its potency even at a dilution of 1:500 (p ≤ 0.01).

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

The aim of this study is to evaluate whether there are bioactive peptides in Atlantic salmon protein hydrolysate (SPH) with glucose-regulating properties, and to conduct a preliminary characterization and evaluation of these peptides. The research focuses on the dipeptidyl peptidase-IV (DPP-IV) inhibitory effect of SPH and its ability to directly promote glucose uptake. Specifically, the objectives of the study include: 1. **Evaluating DPP-IV inhibitory effect**: By inhibiting DPP-IV, the half-life of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) can be extended, thereby enhancing the effect of insulin on glucose homeostasis. This has potential applications in the treatment of diabetes. 2. **Assessing direct glucose uptake ability**: Investigating whether SPH can directly promote glucose uptake in cells (such as muscle cells), which is crucial for improving conditions like insulin resistance and metabolic syndrome. 3. **Preliminary characterization of SPH**: Analyzing the molecular weight distribution and peptide composition to understand the basic characteristics of SPH. The results indicate that low molecular weight (<3 kDa) SPH fractions exhibit significant DPP-IV inhibitory effects and glucose uptake ability. Particularly, the smallest molecular weight peptide fraction (Permeate III) shows the strongest glucose uptake activity, maintaining its bioactivity even at high dilutions. In summary, this study attempts to explore the potential of SPH as a nutritional intervention to improve glucose metabolism and prevent chronic diseases associated with insulin resistance.

Glucoregulatory Properties of a Protein Hydrolysate from Atlantic Salmon (Salmo salar): Preliminary Characterization and Evaluation of DPP-IV Inhibition and Direct Glucose Uptake In Vitro

Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides

Peptide identification in a salmon gelatin hydrolysate with antihypertensive, dipeptidyl peptidase IV inhibitory and antioxidant activities

Peptides from chicken processing by-product inhibit DPP-IV and promote cellular glucose uptake: potential ingredients for T2D management.

Baltic herring hydrolysates: Identification of peptides, in silico DPP-4 prediction, and their effects on an in vivo mice model of obesity

No effect of salmon fish protein on 2-h glucose in adults with increased risk of type 2 diabetes: a randomised controlled trial

Lipid Deposition and Mobilisation in Atlantic Salmon Adipocytes

Identification, Screening, and Comprehensive Evaluation of Novel DPP-IV Inhibitory Peptides from the Tilapia Skin Gelatin Hydrolysate Produced Using Ginger Protease

Exploring the Physicochemical Characteristics of Marine Protein Hydrolysates and the Impact of In Vitro Gastrointestinal Digestion on Their Bioactivity

Omega-3 Polyunsaturated Fatty Acids Promote SNAREs Mediated GLUT4 Vesicle Docking and Fusion

Preparation, identification, activity prediction, and protective effects on IR-HepG2 cells of five novel DPP-IV inhibitory peptides from protein hydrolysate of skipjack tuna dark muscles.

Study on the Hyperglycemic Effect of GLP-1 in Spinibarbus denticulatus by Oral Administration and Intraperitoneal Injection Methods

A novel anti-hyperglycemic sulfated pyruvylated polysaccharide from marine macroalga Hydropuntia edulis

Fish-Derived Protein Hydrolysates Increase Insulin Sensitivity and Alter Intestinal Microbiome in High-Fat-Induced Obese Mice

Metabolic Regulation and Antihyperglycemic Properties of the Diet-derived PGG through Transcriptomic and Metabolomic Profiling

Effects of Short-Term Fasting on mRNA Expression of Ghrelin and the Peptide Transporters PepT1 and 2 in Atlantic Salmon (Salmo salar)

Metabolic Regulation and Antihyperglycemic Properties of Diet-Derived PGG Through Transcriptomic and Metabolomic Profiling

Author Response for "A Novel Α‐glucosidase Inhibitor Polysaccharide from Sargassum Fusiforme"

Functional annotation and enrichment analysis of differentially expressed serum proteins in patients with type 2 diabetes after dapagliflozin

Identification of Anti-Diabetes Peptides from Spirulina Platensis

Screening and identification of a novel antidiabetic peptide from collagen hydrolysates of Chinese giant salamander skin: network pharmacology, inhibition kinetics and protection of IR-HepG2 cells.